Table 2.
Bacterial isolates | Antibacterial susceptibility pattern | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AMP | AMO | CRO | P | CAZ | SXT | CXM | CXC | DA | CXT | ||
S. aureus (n = 42) | S% | 12 (28.6) | 14 (33.3) | 27 (64.3) | 21 (50) | 24 (57.1) | 16 (38.1) | 31 (73.8) | 20 (47.6) | 35 (83.3) | 35 (83.3) |
R% | 30 (71.4) | 28 (66.7) | 15 (35.7) | 21 (50) | 18 (42.9) | 26 (61.9) | 11 (26.2) | 22 (52.4) | 7 (16.7) | 7 (16.7) | |
CoNS (n = 13) | S% | 2 (15.4) | 2 (14.3) | 8 (61.5) | 5 (38.5) | 8 (61.5) | 5 (38.5) | 10 (76.9) | 8 (61.5) | 12 (92.3) | 11 (84.6) |
R% | 11 (84.6) | 11 (85.7) | 5 (38.5) | 8 (61.5) | 5 (38.5) | 8 (61.5) | 3 (23.1) | 5 (38.5) | 1 (7.7) | 2 (15.4) | |
S. pyogenes (n = 2) | S% | 0 (0) | 1 (50) | 4 (100) | 2 (100) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) |
R% | 2 (100) | 1 (50) | 0 (0) | 0 (0) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | |
Total (n = 57) | S% | 14 (24.6) | 17 (29.8) | 39 (68.4) | 28 (49.1) | 33 (57.9) | 22 (38.6) | 42 (73.7) | 29 (50.9) | 48 (84.2) | 47 (82.5) |
R% | 43 (75.4) | 40 (70.2) | 18 (31.6) | 29 (50.9) | 24 (42.1) | 35 (61.4) | 15 (26.3) | 28 (49.1) | 9 (15.8) | 10 (17.5) |
P: penicillin; CAZ: ceftazidime; CXM: cefixime; CXC: cloxacillin; CD: clindamycin; CXT: cefoxitin; S. pyogenes: Streptococcus pyogenes.